Ashland Inc. vs Ecolab Inc. — Stock Comparison
Q·Score Breakdown
5.1
Bearish
Overall
6.6
Neutral
Quality
Health
Growth
Valuation
Sentiment
ASH
Consensus analyst target of $64.60 is 25% above current price.
⚠ currently unprofitable (-39% margin).
ECL
High-quality business with 22% return on equity and 13% profit margins.
⚠ balance sheet warrants attention.
Analyst Consensus
BUY
Target $64.60 (+24.7%)
10 analysts
BUY
Target $317.48 (+22.3%)
21 analysts
Fundamentals
ASH
ECL
—
Trailing P/E
35.1×
11.6×
Forward P/E
27.1×
-39.0%
Profit Margin
12.8%
33.3%
Gross Margin
44.4%
-31.0%
ROE
22.4%
0.6%
Revenue Growth
10.0%
-47.5%
Earnings Growth
7.8%
0.44
Beta
1.02
—
Price / Book
—
$2.4B
Market Cap
$73.3B
$46 – $66
52-Week Range
$249 – $309
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →